Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
123 hedge funds and large institutions have $391M invested in Surmodics in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 42 increasing their positions, 43 reducing their positions, and 16 closing their positions.
0.32% more ownership
Funds ownership: 91.52% → 91.84% (+0.32%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 43
5% less funds holding
Funds holding: 129 → 123 (-6)
18% less capital invested
Capital invested by funds: $477M → $391M (-$85.5M)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
99% less call options, than puts
Call options by funds: $3K | Put options by funds: $304K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.69M |
| 2 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$2.04M |
| 3 |
Millennium Management
New York
|
+$1.5M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$882K |
| 5 |
Norges Bank
Oslo,
Norway
|
+$679K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.26M |
| 2 |
Janus Henderson Group
London,
|
-$1.24M |
| 3 |
Morgan Stanley
New York
|
-$880K |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$723K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$638K |
SRDX Hedge Fund Activity: Q3 2022 in Review
123 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q3 2022, worth a combined $391M — down 18% from $477M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of SRDX and 10 opened new positions — a net loss of 6 holders — while 43 trimmed existing stakes and 42 added.
The largest buyer was Soleus Capital Management, adding an estimated $3.69M. The largest seller was Renaissance Technologies, cutting an estimated $1.26M.
- 123 institutional investors held Surmodics (SRDX) as of Q3 2022, down from 129 in Q2 2022.
- Funds reported $391M of Surmodics stock for Q3 2022, down 18% quarter-over-quarter.
- 10 funds opened new Surmodics positions in Q3 2022 and 16 closed out, a net change of -6 holders.
- The largest Surmodics buyer in Q3 2022 was Soleus Capital Management, an estimated $3.69M added.
- The largest Surmodics seller in Q3 2022 was Renaissance Technologies, an estimated $1.26M sold.
Based on aggregated 13F filings for Q3 2022.